Assisting Screening of Adolescent Depression With Large Language Models as Symptom Detectors: Algorithm Development and Validation

<strong>Background:</strong> Depression prevalence is rising in adolescents and young adults (ages 10-24 years). Traditional screening methods for depression, such as the Patient Health Questionnaire (PHQ-9), are particularly challenging for adolescents. AI has potential to help with this, but the scarcity of annotated datasets highlights the need for off-the-shelf approaches. In this study, we investigate the feasibility of using state-of-the-art large language models (LLMs) to detect depressive symptoms in adolescent settings (ages 15-17 years). <strong>Objective:</strong> This study aimed to evaluate the feasibility of using in-context learning with LLMs to identify depressive symptoms in free-text clinical notes for adolescent populations, to evaluate the feasibility of off-the-shelf LLM configurations in detecting PHQ-9 symptom-related information under zero- and few-shot settings, and to demonstrate the potential clinical utility of LLM-driven evidence extraction through an interpretable AI-based depression screening tool. <strong>Methods:</strong> We examined free text of the electronic health records (EHRs) of adolescent patients with the diagnosis of depression or related mood disorders (age groups 15-17 years, 924 patients) from the Cincinnati Children’s Hospital Medical Center. We leveraged the combination of the Beck Depression Inventory (BDI) and the PHQ-9 to develop tailored categories suited for adolescent depression symptoms. We applied 3 state-of-the-art LLMs (Llama, smaller FLAN-T5, and Phi) to identify these symptom categories in zero- and few-shot configurations, allowing us to assess their performance without additional task-specific training. A word-search model was used as the baseline comparator. <strong>Results:</strong> We manually annotated clinical notes for 22 patients across 16 depression-related symptom categories. Our analysis shows that all LLMs substantially outperformed the word-matching baseline. Within the evaluated prompting configurations, FLAN-T5 achieved the highest precision (average <i>F</i><sub>1</sub>-score=0.65, precision=0.78) and strong performance in detecting rare symptoms such as sleep problems (<i>F</i><sub>1</sub>-score=0.92) and self-loathing (<i>F</i><sub>1</sub>-score=0.80). Phi offered a balanced performance (precision=0.44, recall=0.60), while Llama 3 achieved the highest recall (0.90) but tended to overgeneralize, making it less suitable for precise screening. Within this pilot study, the best-performing LLM exceeded the baseline <i>F</i><sub>1</sub>-score by 0.43. Finally, we demonstrate the clinical utility of FLAN-T5 annotations as features in a machine learning model, which distinguished depression cases from controls with high precision (0.78). <strong>Conclusions:</strong> We used a range of popular LLMs to identify indicators of adolescent (ages 15-17 years) depression symptoms in mental health notes. Within the evaluated configurations, FLAN-T5 demonstrated the most favorable balance between precision and recall. These results support the feasibility of using off-the-shelf LLMs for symptom detection in adolescent clinical notes, while future work using standardized prompting strategies and task formulations will help establish more definitive comparisons between model architectures. The computational efficiency of FLAN-T5 further supports its potential for deployment in resource-limited clinical settings. Our findings require further validation for broader populations and other mental health conditions.

An Education and Support Chatbot for Postpartum Mothers With Opioid Use Disorder: Qualitative Needs Assessment

Background: The prevalence of opioid use disorder (OUD) among women giving birth in US hospitals continues to rise. Increasing fatalities due to perinatal drug overdose have in part been attributed to decreased access to social support and treatment services. In recent years, mobile health (mHealth) technologies have been used to provide care to patients outside of traditional clinical settings. Given that perinatal OUD treatment works best when there is frequent contact between patient and clinician, harnessing mHealth could be valuable for improving patient engagement in perinatal OUD care. Objective: To address the increasing epidemic of perinatal OUD, which is compounded by loneliness and social isolation, this study aimed to adapt an existing mHealth chatbot intervention for postpartum individuals by developing educational and supportive content relevant to people in the postpartum period experiencing OUD and recovery. Methods: We used a participatory design to conduct a needs assessment via in-depth qualitative interviews with patients (n=12) and providers (n=11). Interview data were analyzed using NVivo software (Lumivero) according to a priori codebooks and using inductive coding, which identified major themes to address in a future adaptation of an interactive chatbot. An advisory board was convened to review the data and contribute to content generation that would be most useful for perinatal mothers who are in treatment for OUD. Results: Patients and providers agreed that an interactive chatbot would be useful for patients seeking information on childbirth recovery, substance use recovery, pain management, and infant care, including feeding. Patients specifically wanted a chatbot that felt personal and addressed their individual and specific needs. Providers indicated that the chatbot should address topics that came up frequently in after-hours phone calls to reduce provider burden. Conclusions: Conducting an in-depth participatory-driven needs assessment will support the refinement of an existing chatbot to better meet the needs of a high-risk, difficult-to-reach population. As we move forward to test the chatbot for acceptability and feasibility, data from the needs assessment will support ongoing iterative enhancement of the content, delivery, and safety of the chatbot.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/4711641658d6f7798d35a50de0518027" />

Depressive symptoms and occupational correlates among psychiatric nurses in northern Jiangsu: an explanatory sequential mixed-methods study

BackgroundPsychiatric nurses manage aggression, interrupted recovery and emotionally demanding care. Surveys quantify distress but rarely show how these experiences accumulate during routine work.AimWe aimed to estimate the prevalence of a positive depressive-symptom screen among psychiatric nurses and to quantify its associations with four prespecified occupational exposures: workplace violence, night-shift burden, occupational strain and psychological resilience. A longitudinal qualitative phase then examined how nurses experienced these same exposures during routine work.MethodsFour tertiary public psychiatric hospitals in northern Jiangsu participated from January 2025 to March 2026. A convenience sample of 357 nurses completed the survey. Workplace violence during the preceding 12 months was assessed with Wang’s Workplace Violence Scale; at least one physical, verbal or psychological, or sexual incident perpetrated by a psychiatric inpatient or visiting family member defined exposure. Modified Poisson regression with hospital fixed effects estimated prevalence ratios (PRs) for an SDS-positive screen. A purposive subsample of 20 nurses completed interviews, diaries and observation over three months. Colaizzi’s method and a joint display supported qualitative analysis and integration.ResultsOf 357 nurses, 138 (38.7%) screened positive. Nurses reporting violence had a higher screening prevalence (PR 1.65, 95% CI 1.31–2.08). PRs per SD were 1.48 (95% CI 1.33–1.66) for night-shift burden and 1.45 (95% CI 1.28–1.65) for occupational strain. Resilience showed the opposite pattern (PR 0.79 per SD, 95% CI 0.70–0.88). Qualitative accounts centered on repeated strain, a value–recognition mismatch, unequal recovery resources and support considered generic or poorly timed.ConclusionsDepressive symptoms were common. Nurses identified practical targets: safer work organization, rapid post-incident contact and support tailored to individual circumstances. Cross-sectional estimates do not establish diagnosis or causation.

Psychiatric service dogs reduce loneliness and improve social functioning in adults with mental health conditions: a qualitative study from South Africa

IntroductionLoneliness and impaired social functioning are clinically significant features of mental illness. Psychiatric service dogs (PSDs) are individually trained to perform tasks that mitigate the functional impact of psychiatric disability and have been proposed as an intervention for loneliness and impaired social functioning for their handlers living with mental illness. However, the mechanisms through which they may reduce loneliness and improve social functioning are poorly understood and evidence from low-middle income contexts is almost entirely absent.MethodsThis qualitative study aimed to explore the experiences of PSD handlers in South Africa regarding the impact of their PSD on loneliness, social functioning, and psychosocial well-being across a diverse range of mental illnesses. PSD handlers were recruited through purposive sampling via three South African PSD training organisations. Data were collected through semi-structured individual interviews and analysed using reflexive thematic analysis following the six-phase framework described by Braun and Clarke.ResultsReflexive thematic analysis of participants’ accounts generated six themes describing the psychosocial impact of PSD partnership. Three themes capture the primary mechanisms through which PSD partnership improved social functioning and reduced loneliness: (1) alleviation of loneliness through non-judgmental companionship; (2) PSDs as social catalysts: from brief encounters to sustained relationships; and (3) gains in independence and expanded community participation. Two additional themes describe internal psychological mechanisms: (4) restoration of purpose, meaning, and structured routine; and (5) caregiving as a mechanism of self-regulation and re-engagement. A sixth theme addresses the social costs and challenges of PSD partnership: (6) access discrimination, public scrutiny, and the burden of visibility.DiscussionTogether, these themes describe a multi-layered set of psychosocial processes through which PSD partnership both expanded participants’ social worlds and imposed new burdens upon them. The findings suggest that PSDs may serve as a meaningful adjunctive intervention for loneliness and social isolation in adults with mental illness. Mental health professionals would benefit from greater awareness of PSDs and the psychosocial benefits and challenges associated with their use.

Beyond diagnostic categories: transdiagnostic psychological mechanisms associated with suicidal ideation among university students: a systematic review (2021–2025)

IntroductionConventional diagnostic categories may not fully capture the psychological processes associated with suicidal ideation among university students. This systematic review synthesized recent evidence on candidate transdiagnostic psychological mechanisms, distinguishing ideation-specific findings from broader suicide-related outcomes.MethodsScopus, Web of Science, PubMed, and PsycINFO via EBSCOhost were searched for peer-reviewed observational studies published between January 1, 2021, and December 18, 2025. Study selection followed PRISMA 2020, and methodological quality was assessed using design-specific Joanna Briggs Institute checklists. A narrative synthesis distinguished separately assessed suicidal ideation from complementary findings involving broad death/self-harm indicators, suicide-related cognitions, and composite suicide-risk scores. Classification depended on the outcome analyzed rather than instrument length.ResultsOf 327 records identified, 68 studies were included; 58 were cross-sectional and 10 used longitudinal, prospective, or ecological momentary assessment designs. Findings were organized into cognitive–affective, emotional, behavioral, interpersonal–contextual, and protective domains. Ideation-specific analysis reported associations with hopelessness, repetitive negative thinking, perfectionistic concerns, depressive symptoms, perceived burdensomeness, and entrapment. Associations varied by outcome definition, statistical adjustment, and study design. Inverse or conditional associations involving psychological and interpersonal resources were reported in selected analysis. Complementary findings concerned broader suicide-related outcomes and were interpreted separately rather than as independent replication of ideation-specific associations.DiscussionThe evidence identifies candidate psychological processes for further investigation, but predominantly cross-sectional designs and heterogeneous outcome measures limit causal and temporal interpretation. The proposed framework organizes observational findings rather than validating a causal model. Future prospective research should distinguish outcome constructs, address confounding, and test whether modifying candidate processes reduces suicidal ideation.

Simultaneous measurement of Midbrain and Striatal Dopamine in Schizophrenia using an agonist radiotracer

Imaging studies showing greater amphetamine-induced dopamine release in patients with schizophrenia (SCZ) compared to matched healthy controls (HC) have been repeatedly replicated, but these studies all used radiotracers that were dopamine D2 receptor antagonists. A more recent study using an agonist radiotracer did not detect this increase, raising a question whether the difference in radiotracer pharmacology affected the result. Another study examining the extrastriatal response to the amphetamine challenge with an antagonist tracer observed a blunted effect in SCZ in the midbrain, suggesting mechanisms local to the striatum might have contributed to the striatal imaging results independent of midbrain dopamine availability.

Effect of soft Chinese martial arts on depressive symptoms among college students: a systematic review and meta-analysis

ObjectivesMental health problems are a growing concern among college students worldwide. While exercise is a proven mental health intervention, a quantitative synthesis on the effects of soft Chinese martial arts, as a unique mind-body practice, on depression in this specific population is lacking. This study aimed to fill this gap by systematically evaluating the effectiveness of soft Chinese martial arts interventions in alleviating depressive symptoms among college students.MethodsLiterature with publication dates up to July 31, 2025 was searched in seven databases, including PubMed/MEDLINE, Embase, Web of Science, Scopus, CENTRAL, PsycINFO, and CNKI. Studies were systematically screened according to the PRISMA guidelines, and the quality of the included literature was assessed using the Cochrane Risk of Bias tool. The size of the effect was expressed by means of SMD and 95% confidence interval, and subgroup analyses were performed to explore sources of heterogeneity.ResultsA total of 11 RCTs (11 independent datasets) involving 750 participants were included in the analysis. The meta-analysis revealed a significant overall effect of soft Chinese martial arts on reducing depressive symptoms in college students (SMD = –0.71, 95% CI: –1.23 to –0.18, p = 0.008). Subgroup analyses suggested potential moderating effects of intervention duration, frequency, and session length. For example, the effect size for the 9-14 week subgroup was SMD = –1.35 (95% CI: –2.10 to –0.60) and for the 20-60 minute single session duration subgroup was SMD = –0.69 (95% CI: –1.36 to –0.03). Heterogeneity was high (I2 = 82.6%, p < 0.001). Egger’s test was not statistically significant (p = 0.397), but publication bias cannot be ruled out due to the small number of studies.ConclusionSoft Chinese martial arts, particularly Tai Chi and Baduanjin, may be an effective non-pharmacological intervention for reducing depressive symptoms in college students, providing preliminary evidence for mental health programs. However, results should be interpreted with caution because of high heterogeneity, risk of bias, and possible publication bias. The certainty of evidence is very low according to the GRADE framework.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?RecordID=1129413, identifier CRD420251129413.

The BELONG Study: Black Equality in OCD NeuroGenomics

By Boris Litvin, MA, Matthew Riello, Andrew Marshall, PhD, Emily Rodriguez, MS, MSc, Martha Falkenstein, PhD, and Alexander Rosenberg

BELONG Logo (1) (1)

One word appears more and more in the news surrounding mental health research (and the IOCDF Newsletter and blog): “genomics”. What does it mean, and why is it such a hot topic lately for both scientists and non-scientists? In the context of OCD research, genomics refers to the study of a person’s genome (all of a person’s genes) to gain insight into how OCD appears and develops.

Genomic studies of OCD over the past two decades have contributed significantly to our understanding of how OCD works. However, there remains more to be done and explored, for OCD as well as for other psychiatric conditions.

With support from a five-year grant by the National Institutes of Health (NIH), researchers at the Mount Sinai School of Medicine (New York, NY), Baylor College of Medicine (Houston, TX) and University of North Carolina at Chapel Hill (UNC) (Chapel Hill, NC) have launched the Black Equality in OCD NeuroGenomics (BELONG) study, a research project that looks specifically at the genomes of Black and African Americans with OCD and their families. BELONG aims to contribute to OCD research from multiple perspectives: first, enhancing our overall understanding of OCD genomics, second, achieving a deeper grasp of OCD risk by adding more participants, and, third, gaining more reliable insight into OCD risk by leveraging the power of human diversity.

For the first point, the lead investigator of the BELONG study, together with Dr. Sidney Hankerson, Mount Sinai’s Dorothy Grice, MD, explained: “We know that there are gene variants that significantly increase risk for OCD. When are those genes active developmentally? Can we understand more about where those gene products function in the brain? What part of the brain? What works in partnership with that part of the brain in terms of brain circuitry?”

For the second, Grice added, “Progress in OCD research has been limited by smaller sample sizes compared to other psychiatric conditions, for example, in 2018, there were samples from 130,000 individuals with major depression, about 60,000 individuals with schizophrenia and 20,000 individuals with bipolar disorder and fewer than 3,000 samples from individuals with OCD. These numbers have grown significantly since 2018, but OCD continues to be underrepresented in genetic research. Increasing the sample sizes has tremendous potential to advance our understanding of OCD genetics.”

Third, according to Grice, much of OCD research has mostly involved individuals with European ancestry: “Thinking about OCD and Black Americans, the prevalence is not any different. So it’s not because it doesn’t happen in other cohorts or populations — it’s because those individuals are not being included or not participating for a variety of reasons. So one motivation for our study is to try to get studies in OCD to reflect the real world and the population that’s out there.” Dr. Grice added, “This is a powerful tool to understand the genomics of OCD across all of human ancestry.”

 

Dorothy Grice, MD (Mt. Sinai School of Medicine)

Dorothy Grice, MD (Mt. Sinai School of Medicine)

James Crowley, PhD (University of North Carolina, Chapel Hill)

James Crowley, PhD (University of North Carolina, Chapel Hill)

Bridging Gaps

The number of people participating in OCD genomic studies has grown significantly over the past ten years, which was partly due to the emergence of the international Psychiatric Genomics Consortium (PGC) in 2007. However, the lack of diversity persisted, even for research published by PGC scientists. “This past year, the largest genomewide association study ever was published, with over 53,000 individuals with OCD (Strom et al., 2025),” said Baylor’s Eric Storch, PhD. “Despite all its strengths, virtually no one within the sample was of any sort of racial or ethnic diversity. When you start modeling effects of genetic composition on things like predicting treatment response, it doesn’t represent the beautiful diversity of our world.” Storch continued, “With such a lack, that really has a risk of creating a health disparity where many individuals that comprise our world would not be represented, or not benefit from those discoveries.”

“Humans came out of Africa,” noted UNC’s James Crowley, PhD. “If all of our genetic diversity goes back to Africa, and you focus just on individuals of European ancestry, you are only looking at a fraction of all the genetic diversity on the planet. There have been a lot of initiatives to include genetic data from individuals of African ancestry, and they have not been as successful as we would like. There are systemic barriers to access to assessment, treatment and biomedical research. We have an opportunity in this study to advance biomedical research in the African American community.”

Grice noted that, for Black Americans, “There’s a lot of hesitancy to participate in research studies, given the tragic history in that regard. In addition, we know that there’s a much higher rate of misdiagnosis in Black Americans. People may present with what may be OCD, but there are higher rates of being misdiagnosed as having anxiety or psychosis, even to the point of being inappropriately hospitalized compared to other groups.”

The BELONG team is hopeful that their efforts will contribute to the comparatively small amount of research on OCD in Black Americans. Baylor’s Ogechi “Cynthia” Onyeka, PhD, remarked, “With regards to understanding symptom presentation and expression, the literature on what OCD looks like in the Black community is very limited and restricted to a group of papers that were written 10-15 years ago. We are really excited to pick up where that limited literature has left off and not only understand what some of the symptom dimensions are that might be more prevalent, but also build upon that and get more information out to individuals who might think they have OCD to help support treatment awareness and engagement too.”

 

Eric Storch, PhD (Baylor College of Medicine)

Eric Storch, PhD (Baylor College of Medicine)

Ogechi "Cynthia" Onyeka, PhD (Baylor College of Medicine)

Ogechi “Cynthia” Onyeka, PhD (Baylor College of Medicine)

How BELONG Contributes to Science

How would genomics research contribute to knowledge of OCD, and further advances in treatment? Grice explained, “We’re focusing on rare genetic variation, and particularly de novo variation— which indicates a new, spontaneous genetic change that occurs randomly very early in embryonic development.”

To understand the role of de novo variation, BELONG invites not only Black Americans with OCD to participate, but also their family members, with a goal of at least 1,250 participants by the end of the study. The process for participating in BELONG is fairly simple, and anyone in the US can take part. Storch explained, “Go to our website (https://belongocd.com/), or email one of us. From there it’s a simple interview and mailing us a saliva sample via a kit that we provide. We also provide some compensation to participants for their time and effort.”

Naturally, concerns about the safety of DNA collection and storage can arise. “There’s a lot of oversight and attention to ensure our study is compliant with all the current ethical and confidentiality rules that are in place on every level,” Grice said. Crowley added, “First: there’s no for-profit institution involved in any of this research. Second: we remove all identifiers, like name, birthplace, and date of birth. All of that information is stripped from any of the genetic data. Third: the way that we work with the data is very controlled and regulated by each institution’s ethical review board.”

Importantly, this security extends to research conducted by future researchers who may access the data for years to come. The BELONG team adheres to strict federal and institutional standards to promote the safety of participants. Like many studies funded by the NIH, BELONG data will be available for future research. “With the consent of each participant, we share their anonymous information with NIH because NIH has a data repository available to other vetted and qualified researchers who can extend our work,” Grice specified. “The participants are doing so much for our study and if a researcher comes along in ten years with a great new idea that can benefit the field, they can apply to use this information. Every participant in BELONG is advancing knowledge of OCD today and in the future. And that’s fantastic.”

It all comes back to the participants. “We try to answer questions, make sure people feel comfortable about participating — that’s all a part of the informed consent process, to make sure that all the questions are answered about why we’re doing this study, what the study entails and how the participants are protected, before they actually get into the study. We want people to understand what it’s all about and make sure they have the knowledge that they need to make an informed decision about whether they want to join or not,” said Grice.

 

Beyond BELONG

While the BELONG study highlights and addresses major gaps in both genomics and OCD research, it is important to be mindful that all research has limitations, especially with the interpretation and extrapolation of data. Fellow scientists and clinicians like Sonya Faber, PhD, at the University of Ottawa warned that the results of genetic research could be misconstrued to “reinforce scientific racism and biological determinism, rather than addressing the structural and psychosocial contributors to mental health disparities.” Faber also noted that racially-based genetic studies could “risk excluding or misclassifying participants of mixed ancestry—who often face the same structural barriers but may be excluded for not fitting a clean racial “genetic” category”. Grice notes that African Americans are overwhelmingly of mixed ancestry and hence the BELONG study is in a unique position to address these risks. Similarly, Emory University School of Medicine’s Donovan Ellis, PhD, expressed, “[We want] to be mindful that we’re not reifying race science-based conclusions, or coming to the types of conclusions that unintentionally further marginalize communities, or be overly narrow”.

Both Faber and Ellis asserted that genetic risk factors for psychological disorders are not tied to race. Citing genetic research into schizophrenia, Faber explained, “Although there are now genes associated with the risk of developing schizophrenia, these do not directly correspond to higher risk by race, as race is a sociopolitical and not a genetic classification” (Faber et al., 2023). “This logic applies equally to OCD,” she stated.

Emory University clinical psychologist Joya Hampton-Anderson, PhD, suggested that this important study should ensure to carefully consider the cultural context and historical stigma associated with medical research and minority groups: “I think the alignment with the community is going to be really important with something like saliva samples being taken. There is a lot of historical mistrust in the Black community around medicine, broadly defined, but also research, and that is a very intimate data collection method.”

With these concerns in mind, Faber described how epigenetic factors may play a role in linking genetics with OCD. Epigenetics refers to how one’s behavior or environment can impact and interact with their own genome. “Since belonging to a certain race corresponds to an environmental risk of poor mental health (i.e., social disadvantage)…an association between race and [mental disorders] may be expected to be observed,” said Faber; these risks may include “chronic exposure to racism, discrimination-related stress, intergenerational trauma, and environmental adversity (housing, pollution, policing, poverty)”. Faber continued, “Epigenetics provides a far more accurate and justice-consistent framework for understanding why racially minoritized groups may show different biological profiles—without invoking race as a proxy for genetic difference”.

Faber concluded citing Bryant et al. (2022): “While ethnicity allows individuals the agency to self-define through shared culture and ancestry, race is an artificial category externally imposed to rank and divide human variation. Decades of genetic data confirm that race is not a proxy for genetics, but rather a proxy for the impacts of structural racism”.

 

Advancing OCD Research, One Saliva Sample at a Time

The BELONG researchers have acknowledged these concerns head-on. Regarding potentially reinforcing biological determinism, Grice explained, “We’re not thinking there will be different genes involved compared to other ancestries, but given all the ancestral population changes and genetics, there probably will be different genetic variants within a particular gene, which will help us to learn more about the biology of OCD, because not all genetic variation actually leads to a problem”. In fact, Grice notes that other ongoing psychiatric genetic studies in autism and schizophrenia that also focus on rare de novo variation do not show evidence for different biological profiles across different ancestries, so there is good reason to think these issues will be moot in BELONG.

Grice also clarified: “This study is focusing on genetics which plays a very important role in risk for OCD, and while there are also important non-genetic or environmental factors, those are not a focus of this particular study. We’re not saying it’s all genetic, but that is what we’re focusing on in BELONG”.

Recognizing the complex history of medical research involving minority communities, Onyeka reiterated that “We have a community advisory board that we’ve been working with, with different clinicians who are Black who work within this space in terms of providing treatment and therapy, and getting feedback from folks who are on the ground and actually engaging with these patients has also been helpful too”.

Despite genetics being the focus of the study, Onyeka mentioned that working directly with minority communities can provide insight into the environmental factors that shape OCD  “I think one thing that I’m really excited about is the phenotypic component of this study. In addition to getting a really good assessment of OCD with the participants, we’re also getting a lot of different perspectives about different socioecological factors that might be related to OCD. Things like ethnic identity membership and awareness of treatment of symptoms and other things that, with a large sample, we hope to obtain”.

Jordan Cattie, PhD, of Emory University School of Medicine expressed, “Researchers can build trust by using approachable, clear, and informative language about how a study can help, or is different from previous work. For example, this study team shared that (in both existing genetics and OCD treatment studies) there is significant underrepresentation of Black Americans, which makes representation a really important priority. This study team is unique in including a community advisory board that focuses on how to make research helpful for communities, as well as health equity researchers.”

Many researchers and clinicians remain hopeful about the prospects of this research and understand its importance in expanding the knowledge of OCD risk.

“Ultimately, BELONG represents a unique research study that goes beyond the laboratory. This research is really grounded in altruism,” said Onyeka. “It’s a one-time experience for the participant — to be able to meet for the assessment, get an understanding of what OCD looks like for them, have the validation of talking to somebody about their symptoms, which can be really validating and helpful and affirming, and then participate with regards to the genetic component. But the dividends of that participation go far beyond what we can even operationalize or quantify right now, which is something that’s really incredible and not something that you see a lot with research in the Black community. I think just what makes this study really unique is how far your participation can go.”

 

 

References

Bryant, B. E., Jordan, A., & Clark, U. S. (2022). Race as a Social Construct in Psychiatry Research and Practice. JAMA psychiatry, 79(2), 93–94. https://doi.org/10.1001/jamapsychiatry.2021.2877

Faber, S. C., Khanna Roy, A., Michaels, T. I., & Williams, M. T. (2023). The weaponization of medicine: Early psychosis in the Black community and the need for racially informed mental healthcare. Frontiers in psychiatry, 14, 1098292. https://doi.org/10.3389/fpsyt.2023.1098292 

Strom, N.I., Gerring, Z.F., Galimberti, M., Yu, D., Halvorsen, M.W., Abdellaoui, A., Rodriguez-Fontenla, C., Sealock, J.M., Bigdeli, T., Coleman, J.R., Mahjani, B., Thorp, J.G., Bey, K., Burton, C.L., Luykx, J.J., Zai, G., Alemany, S., Andre, C., Askland, K.D., Bäckman, J., … Mattheisen, M. (2025). Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. Nature Genetics, 57(6), 1389–1401. https://doi.org/10.1038/s41588-025-02189-z 

The post The BELONG Study: Black Equality in OCD NeuroGenomics appeared first on International OCD Foundation.

Targeted Brain Ultrasound Could Help Relieve Schizophrenia Symptoms

Results from a small pilot study show transcranial ultrasound stimulation, using low-intensity targeted sound waves, can improve delusions in people with schizophrenia or schizoaffective disorder.

As reported in the journal npj Acoustics, participants’ delusion scores fell by an average of 1.2 points relative to their pre-session scores after active ultrasound, compared with an average 0.4-point increase after a control “sham” treatment.

While this difference is statistically significant, the study was small with only 10 patients, so further work is needed to confirm the results of this pilot study. “These promising early findings suggest that further work is needed to establish whether targeted ultrasound could one day supplement or even replace standard medicines for schizophrenia,” said lead study author Donald Goff, MD, NYU Grossman School of Medicine, in a press statement.

Low-intensity transcranial ultrasound stimulation is being investigated as a possible treatment for depression, pain, epilepsy, Parkinson’s disease and Alzheimer’s disease, as well as schizophrenia. So far the greatest evidence base is probably for treatment of depression, but this type of ultrasound is still at the experimental stages for these different indications.

“Unlike other emerging techniques that modulate brain circuits, transcranial ultrasound stimulation offers a unique opportunity to precisely target very small regions that affect thinking and behavior,” said study co-senior author Shy Shoham, PhD, a professor of neuroscience and ophthalmology at NYU Grossman School of Medicine.

In the current study, the researchers recruited ten adults with schizophrenia or schizoaffective disorder and ongoing psychosis. In a randomized crossover design, each participant received two sessions one week apart: active transcranial ultrasound stimulation and sham stimulation, in random order. Six participants continued stable antipsychotic treatment during the study and four were not taking antipsychotics.

Using magnetic resonance imaging-guided navigation, the team delivered ten minutes of pulsed ultrasound to the right globus pallidus internus, a deep-brain structure involved in psychosis. Delusions and auditory hallucinations were assessed before, during and after each session and cognition and adverse effects were also measured.

Transcranial ultrasound reduced delusion scores by 1.56 points versus sham treatment. However, the treatment did not significantly change auditory hallucinations or cognition. No serious adverse events occurred. Mild headaches, fatigue and gastrointestinal discomfort were seen in both the treatment and control treatment groups.

“Globus pallidus interna-targeted transcranial ultrasound stimulation was safe, well-tolerated, and associated with a preliminary reduction in delusional severity, warranting further study in larger, randomized trials,” conclude the authors, although they caution that “the findings should be considered preliminary and require replication and extension in larger randomized controlled trials.”

The post Targeted Brain Ultrasound Could Help Relieve Schizophrenia Symptoms appeared first on Inside Precision Medicine.

Diagnostic and predictive value of structural and high-order functional brain topology in major depressive disorder

BackgroundConventional neuroimaging analyses for major depressive disorder (MDD) predominantly construct brain networks based solely on pairwise regional functional couplings. Accumulating microscale neuroscientific evidence highlights the essential role of higher-order interactions (HOIs, interactions among three or more brain nodes) in capturing the intricate spatiotemporal dynamics of the human brain. This study aims to integrate machine learning techniques with neuroimaging topological features to systematically investigate the impact of non-pairwise interaction patterns in the brains of MDD patients on system dynamics, and to develop diagnostic and predictive models for MDD clinical manifestations.MethodsFirstly, diffusion tensor imaging (DTI) and resting-state functional magnetic resonance imaging (rs-fMRI) data were acquired from 154 MDD patients with first-episode, drug-naïve and 153 age and gender matched healthy controls (HCs). Graph-theoretical analysis was applied to DTI-derived tractography data to quantify structural topology metrics, whereas persistent homology was adopted to extract higher-order functional topological signatures from rs-fMRI time series. Second, feature-level fusion was performed, and then a classification model was constructed using support vector machine (SVM) for MDD diagnosis. A repeated nested validation strategy with 50 repeated stratified 70/30 hold-out splits was adopted. Classification performance was evaluated using the area under the receiver operating characteristic curve (AUC). Subsequently, a prediction model was built based on the selected fused features using ridge regression, and the prediction performance was evaluated based on the correlation between the predicted values and the actual scale scores.ResultsCompared with HC, MDD patients exhibited significant alterations in structural and functional topological metrics within key brain networks, including DMN, VN and FPN. The classification performance of the SVM model integrating multimodal neuroimaging features achieved excellent classification performance, with an AUC of 88.2%. Additionally, multimodal imaging features demonstrated robust predictive capacity for suicide risk level in MDD patients (r=0.604).ConclusionBy integrating structural and higher-order functional topological features, we are able to effectively diagnose and predict MDD, highlighting the crucial role of higher-order interactions in the pathological mechanisms of brain networks in depression.